Is Besudil covered by medical insurance? How much do patients need to pay after medical insurance reimburses them?
Besudil has been officially launched in China and has been included in the medical insurance reimbursement catalog, which means that eligible patients can enjoy a certain reimbursement ratio through medical insurance. For some patients who require long-term treatment, medical insurance support greatly reduces their financial burden. Patients can purchase Besudil through hospital pharmacies, and after medical insurance reimburses them, the cost they need to pay will be relatively low. However, since the proportion of medical insurance reimbursement varies from region to region, the specific payment costs need to be confirmed by the patient with the local hospital pharmacy.
After reimbursement by medical insurance, the patient's payment will vary depending on the region. Specifically, in some places, medical insurance coverage is relatively comprehensive and the reimbursement ratio is relatively high. Patients may only need to pay a few thousand yuan to about 10,000 yuan. In some areas where medical insurance reimbursement rates are lower, patients may need to pay more. Generally speaking, the cost borne by the patient after medical insurance is reimbursed will be much cheaper than the full self-payment, but the specific cost still needs to be confirmed according to the medical insurance policy of the patient's region.
In addition to domestic original drugs, there are also generic versions of Besudil on sale in overseas markets, and the prices are relatively affordable. Taking regions such as Laos as an example, the price of generic Besudil is about 4,000 yuan, which is significantly lower than the price of domestic original drugs. Generic drugs are similar to brand-name drugs in terms of ingredients and efficacy, so some patients choose to purchase generic drugs to save on treatment costs. Although domestic patients are not yet able to purchase generic drugs through formal channels, in some countries and regions, generic drugs have become a more economical option.
Reference: https://www.rezuomib.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)